STTCOMP PAA FA Long Soi 387 mil Mkt cap $147 mil Last traded 38 cents
PAA ia biotech company conducting trials for treatment of MND Motor Nueron Disease Released results of phase 2 trials after market today. I sold out of PAA Friday but todays results are great. No safety issues and the bottom line is Using the prognostic predictor model described in Elamin et al., 2015, 1 depending on the current severity of the disease, a 0.48 slope change as calculated for all 12 patients could provide patients with an additional 13.5- 56.5 months in median survival. Currently approved treatments for ALS/MND provide approximately 2 – 9 months in additional life expectancy.
So PAA kick life expectancy 5 times longer than the current $1 b companies treatment.
